00 days
00 hrs
00 mins
00 sec
Adult Hematology Program Pediatric Hematology & Oncology Nursing Oral & Poster Presentations

pdf-icon.pn



10 NOVEMBER 2021
ADULT HEMATOLOGY PROGRAM
08.20-08.30
 OPENING REMARKS OF EHOC 2021
SESSION 1 - SMOP SESSION Mind the Gap: Outcomes,Trends and Lessons Learned
 CHAIRS: Zeba Aziz - Serdar Bedii Omay
08.30-08.45
 Patterns of Treatments & Outcomes In Relapsed DLBCL In LMICs
 Muneera Moosajee
08.45-09.00
 Predictors of Outcomes and Survival Analysis in Prostate Cancer-Data From AnTertıary Care Urology Instiute
 Najeeb Niamatullah
09.00-09.15
 Colorectal Cancer: Local Perspective in the Era of Precision MedicineAdnan Jabbar
09.15-09.30
GENERAL DISCUSSION Chair: Ahmet İfran
SESSION 2 - ISRAEL SOCIETY OF HEMATOLOGY SYMPOSIUM
 CHAIRS: Irit Avivi - Filiz Vural
09.30-09.50
 Digital Tools in Medicine in 2021 
 Moshe Mittelman
09.50-10.10
 Treating AML in the Era of Targeted Therapy - Challenges and Opportunities
 Ofir Wolach
10.10-10.20
 GENERAL DISCUSSION Chair: Mahmut Töbü
10.20-10.40COFFEE BREAK

SESSION 3 - ELN HIGHLIGHTS SESSION : ELN: Progress with Chronic Leukemias

CHAIRS: Rudiger Hehlmann - Mehmet Ali Özcan
10.40-10.55
 ELN Recommendations for Treating CML 
 Rudiger Hehlmann
10.55-11.10
 ELN Recommendations for Treating MDS
 Theo de Witte
11.10-11.25
 ELN Recommendations for Treating MPN
 Tiziano Barbui
11.25-11.40
GENERAL DISCUSSION Chair: Deniz Sargın
11.40-12.20
 SATELLITE SYMPOSIUM - Hemophilia Care in Turkey and continued role of pdFVIII
kedrio.png		 CHAIRS: Birol Güvenç - SPEAKER: Prasad Mathew
SESSION 4 - ROHS SESSION
 CHAIRS: Natalia B. Mikhailova - Oral Nevruz
12.20-12.40
 Target and Immunotherapy in Patients with Agressive B Cell lymphoma: Pavlov University Experience
 Kirill V. Lepik
12.40-13.00
 Allogeneic Hematopoetic Stem Cells Transplantation for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma in the Era of Immunotherapy
 Anastasia V. Beynarovich
13.00-13.10
GENERAL DISCUSSION Chair: Ferit Avcu
13.10-14.10
LUNCH BREAK
SESSION 5 - ABHH SESSION
 CHAIRS: Dante Mário Langhi Júnior - Salih Aksu
14.10-14.25
 Generic Imatinib x Gleevec
 Katia Pagnano
14.25-14.40
 T-CELL Project
 Carlos Chiattone
14.40-14.55
 CAR-T Cell
Renato Cunha
14.55-15.10
GENERAL DISCUSSION Chair: Mehmet Sönmez
SESSION 6: ASFA
 CHAIRS: Joseph Schwartz - Ali Ünal
15.10-15.25
 Preparation and Changes to Apheresis Facilities Practices During the COVID-19 Pandemic 
 Jeff Winters
15.25-15.40
 The use of Apheresis , E.G.  TPE in patients with COVID-19
 Ravi Sarode
15.40-15.55
 Review of New Indication - Journal of Clinical Apheresis Preseptective 
 Huy Pham 
15.55-16.10
GENERAL DISCUSSION Chair: Şehmus Ertop
16.10-16.30
COFFEE BREAK
SESSION 7 - AABB SESSION
 CHAIRS:Robert Weinstein -Birol Güvenç
16.30-16.50
 Biomanufacturing Challenges in Advanced Cell Therapies
 Andrew Fesnak
16.50-17.10
 Hematopoietic Cell Transplantation: Lessons Learned and Future Direction
 Tom Spitzer
17.10-17.20
GENERAL DISCUSSION Chair: Orhan Ayyıldız
SESSION 8 - HIGHLIGHTS OF SOHO SESSION
 CHAIRS:Hagop Kantarjian - Osman İlhan
17.20-17.35
 SOHO State of the Art & Next Questions: AML
 Hagop Kantarjian
17.35-17.50
 SOHO State of the Art & Next Questions: ALL
Elias Jabbour
17.50-18.05
 SOHO State of the Art & Next Questions: MDS
Guillermo Garcia Manero
18.05-18.20
 SOHO State of the Art & Next Questions: CLL
Susan O'Brien
18.20-18.40
GENERAL DISCUSSION Chair: Zafer Gülbaş



11 NOVEMBER 2021
ADULT HEMATOLOGY PROGRAM
07.40-08.40
 ORAL PRESENTATION SESSIONS 1
 Anıl Tombak, Hüseyin Saffet Beköz,Şebnem İzmir Güner
ADULT & PEDIATRIC ONCOLOGY JOINT SESSION JOINT SESSION IN BASIC ONCOLOGY
 CHAIRS: Nikolay Tupitsyn - Nur Olgun
08.40-09.00
 Genetic Predisposition to Pediatric Cancer
Uğur Özbek
09.00-09.20
 Precision Medicine in Cancer
 Ferda Pınarlı
09.20-09.40
 Inflammation and Cancer Jean Francois Rossi
09.40-10.00
 Cancer Stem Cells: Theories and FactsBob Gale
10.00-10.20
GENERAL DISCUSSION Chair: Safiye Aktaş
10.20-10.40COFFEE BREAK
ADULT & PEDIATRIC HEMATOLOGY JOINT SESSION IN HAEMOGLOBINOPATHIES
 CHAIRS: Domenica Capellini - Zeynep Karakaş
10.40-11.00
 Evaluation of Iron Load in Patients with Haemoglobinopathy
 Yeşim Aydınok
11.00-11.20
 "BMT in Children with Thalassemia in Turkey"
 Akif Yeşilipek
11.20-11.40
 Thalassemia Treatment
Domenica Capellini
11.40-12.00
 Treatment of Sickle Cell in 2021
 Salam Al Kindi
12.00-12.20
 GENERAL DISCUSSION Chair: Göksel Leblebisatan
12.20-13.20LUNCH BREAK
13.20-14.00
 SATELLITE SYMPOSIUM-Carfilzomib in the Treatment of Relaps Refractory Multiple Myeloma
amge.png		 CHAIRS: Hakan Göker - SPEAKER: Anıl Tombak
14.00-14.40
 SATELLITE SYMPOSIUM
Response, Control and Survival with Ruxolitinib in Myelofibrosis
Polycythemia Vera Management with Ruxolitinib
novartis2.png		 CHAIRS: Sevgi Kalayoğlu Beşışık - SPEAKER: Ömür Gökmen Sevindik
Mehmet Hilmi Doğu

SESSION 9 - CHRONIC MYELOID LEUKEMIA

CHAIRS: Naeem Chaudhri - Emin Kaya
14.40-15.00
 Treatment of Resistant Disease with Registered TKI
 Naeem Chaudhri
15.00-15.20
 How Can We Implement TFR in Clinical Practice?
 Carmen Fava
15.20-15:40
 Innovative Treatment Options
Andreas Hochhaus
15.40-16.00
 Still a Role for IFN in CML?
Tomasz Sacha
16.00-16.20
GENERAL DISCUSSION Chair: Levent Ündar
16.20-16.40
 COFFEE BREAK
SESSION 10 - MULTIPLE MYELOMA
 CHAIRS: Ahmad Ibrahim - Zahit Bolaman
16.40-17.00
 MRD Detection in MM: Methods and Prognostic Significance
 Evangelos Terpos
17.00-17.20
 Treatment of Relapsed, Refractory Multiple Myeloma: Focus on New Drugs
 Angelo Maiolino
17.20-17.40 First Line Therapy for Multiple Myeloma: Open Issues Maria-Victoria Mateos
17.40-18.00 Management of Waldenstrom Macroglobulinemia in 2020 Ahmad Ibrahim
18.00-18.20
GENERAL DISCUSSION Chair: Sevgi Kalayoğlu Beşışık
18.20-19.00
 SATELLITE SYMPOSIUM - Optimal Treatment With IMIDs in MM
deva.png

CHAIRS:

Birol Güvenç 

SPEAKER: 

Tülin Tuğlular

Maria Mateos
19.00-19.40 E-POSTER PRESENTATIONS SESSION 1 Mehmet Ali Uçar,Müzeyyen Aslaner


12 NOVEMBER 2021
ADULT HEMATOLOGY PROGRAM
07.40-08.40
 ORAL PRESENTATION SESSIONS 2
 Oktay Bilgir, İlhami Kiki, Alpay Yeşilaltay
SESSION 11 - New Thinking on Glanzmann Thrombasthenia: When Function Dominates and COAGULATION PROBLEMS
 CHAIRS: Drew Provan - Bülent Zülfikar
08.40-09.00
 Hemophilia
 Margareth C. Ozelo
09.00-09.20
 New Thinking on ITP
 Drew Provan 
09.20-09.40
 New Thinking on Glanzmann Thrombasthenia: When Function Dominates
 Hanan Hamed
09.40-10.00
 Coumadin and New Oral Anticoagulants: Which and When
 Özgür Mehtap
10.00-10.20
 GENERAL DISCUSSION Chair: Selami Koçak Toprak 
10.20-10.40
COFFEE BREAK

SESSION 12 - CHRONIC LYMPHOCYTIC LEUKEMIAS AND INDOLENT LYMPHOMAS

 CHAIRS: Robin Foà - Berksoy Şahin
10.40-11.00 Current Therapy of CLL 
 Antonio Cuneo
11.00-11.20 Indolent Lymphomas
 Carmino de Souza 
11.20-11.40 New Drugs for Low Grade Lymphoproliferative Disease 
 Argiris Simeonidis
11.40-12.00 Can We Cure CLL? 
  Robin Foà
12.00-12.20 GENERAL DISCUSSION Chair: Mehmet Turgut
12.20-13.20
LUNCH BREAK
13.20-14.00
 SATELLITE SYMPOSIUM-The Rising Role of Venetoclax in the Era of Novel CLL Therapies
abbvi.png		 CHAIRS: Burhan Ferhanoğlu - SPEAKER: Mehmet Ali Özcan
SESSION 13 - SPECIAL TOPICS FOR LYMPHOMAS  
 CHAIRS: Anna Maria Sureda Balari - Burhan Ferhanoğlu
14.00-14.20
 Treatment of Relapsed/Refractory Diffuse large B Cell Lymphoma Burhan Ferhanoğlu
14.20-14.40
 Treatment of R/R Hodgkin Lymphoma
 Anna Maria Sureda Balari
14.40-15:00
 Response adapted maintenance therapy in FL:Lessons from the FOLL12 Trial
 Massimo Federico
15.00-15.20
 Treatment of R/R Follicular Lymphoma
 Stefano Luminari
15.20-15.40
 GENERAL DISCUSSION Chair: Olga Meltem Akay
15.40-16.00
COFFEE BREAK  

SESSION 14 - TRANSPLANTATION  

 CHAIRS: Arnon Nagler - Seçkin Çağırgan   
16.00-16.20
 Haplo vs MUD transpplant
 Arnon Nagler
16.20-16.40
 GVHD Treatment
 Elif Birtaş Ateşoğlu 
16.40-17.00
 Car-T Cell 
 Francesco Saglio
17.00-17.20
 Reduced Intensity Conditioning Treatment: Current View 
 Daniela Cilloni
17.20-17.40
 GENERAL DISCUSSION Chair: Hakan Göker
17.40-18.20
 SATELLITE SYMPOSIUM-Immunotherapies and Increased Opdivo Experiences in Turkey in the Treatment of R / R Hodgkin Lymphoma
bmsx50.png		 CHAIRS: Birol Güvenç - Mustafa Çetiner - SPEAKER: Mehmet Ali Özcan
SESSION 15 -   ACUTE LYMPHOBLASTIC LEUKEMIA  
 CHAIRS:Dieter Hoelzer  - Gülsüm Özet
18.20-18.40
 European Vision of ALL Treatment
 Dieter Hoelzer (Debate)
18.40-19.00
 American Vision of ALL Treatment
 Hagop Kantarjian (Debate)
19.00-19.20
 T-Cell ALL 
 Ali Bazarbachi
19.20-19.40
 Ph-Positive ALL 
 Robin Foà
19.40-20.00
 GENERAL DISCUSSION Chair:Sema Anak


13 NOVEMBER 2021
ADULT HEMATOLOGY PROGRAM
07.40-08.40
  ORAL PRESENTATION SESSIONS 3
 Demet Çekdemir, Güven Çetin, Vahap Okan
SESSION 16- ACUTE MYELOID LEUKEMIA
 CHAIRS: Charles Schiffer - Erdal Kurtoğlu
08.40-09.00
 Essential Molecular Characterisation of AML Patients
 Mehmet Yılmaz
09.00-09.20
 How I Treat AML 
 Charles Schiffer 
09.20-09.40
 Targeted Therapy in AML Treatment
 Giovanni Martinelli
09.40-10.00
 Importance of Mınımal Residual Diesease Detection in AML Treatment 
 Claudio  Cerhcione
10.00-10.20
 GENERAL DISCUSSION Chair: Düzgün Özatlı
10.20-10.40
COFFEE BREAK
Session 17 : Ph-NEGATIVE AND POSITIVE MPNs 
 CHAIRS: Tariq Mughal - Ayşe Tülin Tuğlular
10.40-11.00
 How I Treat Policytemia Vera 
 Francesco Passamonti
11.00-11.20
 How I Treat Myelofibrosis 
 Tariq Mughal
11.20-11.40
 When Standard TKIs Do Not Suffice 
 Pia Ranani
11.40-12.00
 How I Treat Essential Thrombocythemia
 Güray Saydam 
12.00-12.20
 GENERAL DISCUSSION Chair: Ömür Gökmen Sevindik
12.20-13.20
 LUNCH BREAK
13.20-14.00
 BREAK
Session 18: MDS
 CHAIRS: Rajko Kusec  - Mustafa Nuri Yenerel
14.00-14.20
 MDS Diagnosis - Often Easy - Occasionally Challenging
 Moshe Mittelman 
14.20-14.40
 How I Treat MDS 
 Guillermo Garcia Manero
14.40-15:00
 New Drugs for MDS 
 Elias Jabbour
15.00-15.20
 Luspatercept in MDS 
 Mustafa Çetiner
15.20-15.40
 GENERAL DISCUSSION Chair: Ant Uzay
15.40-16.00
 COFFEE BREAK
Session 19:  NEW BIOLOGICAL INSIGHTS INTO THE HEMATOLOGICAL DISEASES 
 CHAIRS: Vera Donnenberg - Nilgün Sayınalp
16.00-16.15
 Evolution of the Pleural Secretome Associated with Pleural Metastasis. 
 Albert  Donnenberg
16.15-16.30
 Intrapleural Therapy to Drive Systemic Anti-Tumor Immunity 
 Vera Donnenberg
16.30-16.45
 The Promising Role of the HDHODH Inhibitors in the Therapy of Acute and Chronic Myeloid Leukemias 
 Mohammad Houshmand
16.45-17.00
 Congenital Erythrocyte Defects of the Paediatric Age 
 Achilles Iolascon
17.00-17.15
 Invasive Fungal Infections in Heamatological Patients in COVID-19 Pandemic
 Ömrüm Uzun
17.15-17.30
 GENERAL DISCUSSION Chair: Pervin Topcuoğlu
17.30
 CLOSING